Innovative biotech company AdAlta (ASX: 1AD) has been approved to commence human clinical trials for its next generation of protein…
Melbourne-based drug development company AdAlta (ASX: 1AD) has been selected by GE Healthcare, one of the world’s largest healthcare companies,…